Royalty Pharma director Bassler acquires 642 shares

Royalty Pharma plc (RPRX) director Bonnie L. Bassler acquired 642 Class A Ordinary Shares on September 30, 2026, under the 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) director Bonnie L. Bassler acquired 642 Class A Ordinary Shares on September 30, 2026, under the 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. Her direct holdings following the award were 79,823 shares.

Insider Trade Summary

Grant/Award: 642 shares

Grant/Award 1 txn

Insider Bassler Bonnie L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Ordinary Shares F1	642	$58.4055	$37K

Holdings After Transaction: Class A Ordinary Shares — 79,823 shares (Direct)

Footnotes (1)

1. F1. Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Key Figures

Shares acquired: 642 shares Quarterly retainer payment: $37,500 Direct holdings after award: 79,823 shares

3 metrics

Shares acquired 642 shares September 30, 2026

Quarterly retainer payment $37,500 Payment replaced by the share issuance

Direct holdings after award 79,823 shares Following the September 30, 2026 transaction

Key Terms

Class A Ordinary Shares, 2020 Independent Director Equity Incentive Plan, quarterly retainer

3 terms

Class A Ordinary Shares financial

"Reflects Class A Ordinary Shares issued to the Reporting Person"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

2020 Independent Director Equity Incentive Plan financial

"under the Issuer's 2020 Independent Director Equity Incentive Plan"

quarterly retainer financial

"in lieu of a quarterly retainer payment of $37,500"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares did director Bonnie L. Bassler receive?

Bonnie L. Bassler acquired 642 Class A Ordinary Shares on September 30, 2026. Royalty Pharma plc issued them under its 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500; her direct holdings following the award were 79,823 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/30/2026 - 04:33 PM Accepted by SEC EDGAR 09/30/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bassler Bonnie L

(Last) (First) (Middle)

C/O ROYALTY PHARMA PLC

110 E. 59TH STREET

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Royalty Pharma plc [ RPRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Shares	09/30/2026		A		642	A	$58.4055(1)	79,823	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Remarks:

	/s/ Sean Weisberg, as Attorney-in-Fact for Bonnie L. Bassler	09/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)